Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Next Science Limited
  6. News
  7. Summary
    NXS   AU0000041329

NEXT SCIENCE LIMITED

(NXS)
  Report
Delayed Australian Stock Exchange  -  01:11 2022-10-07 am EDT
0.7500 AUD   -6.25%
08/26Next Science Secures License for Wound Cleaning Product in Canada
MT
08/25Next Science Limited Announces Health Canada Given Licensing Approval for XPERIENCE
CI
08/24Transcript : Next Science Limited, H1 2022 Earnings Call, Aug 25, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Next Science Secures Australia, New Zealand Distributor for Wound Dressing Product

05/19/2022 | 03:21am EDT


© MT Newswires 2022
All news about NEXT SCIENCE LIMITED
08/26Next Science Secures License for Wound Cleaning Product in Canada
MT
08/25Next Science Limited Announces Health Canada Given Licensing Approval for XPERIENCE
CI
08/24Transcript : Next Science Limited, H1 2022 Earnings Call, Aug 25, 2022
CI
08/24Next Science Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
07/25Next Science : Investor Presentation - Q2 2022
PU
05/27Next Science CEO to Resign Before June 30, 2023
MT
05/27Transcript : Next Science Limited - Shareholder/Analyst Call
CI
05/26Next Science Limited's Judith Mitchell to Step Down as Chief Executive Officer
CI
05/19Next Science Secures Australia, New Zealand Distributor for Wound Dressing Product
MT
05/18Next Science Limited Signed Multi-Year Distribution Agreement with Oraderm Pharmaceutic..
CI
More news
Financials (USD)
Sales 2022 16,4 M - -
Net income 2022 -7,28 M - -
Net cash 2022 10,8 M - -
P/E ratio 2022 -11,5x
Yield 2022 -
Capitalization 111 M 111 M -
EV / Sales 2022 6,09x
EV / Sales 2023 3,21x
Nbr of Employees -
Free-Float 47,2%
Chart NEXT SCIENCE LIMITED
Duration : Period :
Next Science Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEXT SCIENCE LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 0,51 $
Average target price 1,32 $
Spread / Average Target 157%
EPS Revisions
Managers and Directors
Judith Mitchell Chief Executive Officer, Director & MD
Jacqueline Butler Chief Financial Officer
Mark R. Compton Non-Executive Chairman
Matthew Myntti Chief Technology Officer
Jon Swanson Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
NEXT SCIENCE LIMITED-39.76%111
JOHNSON & JOHNSON-5.35%425 691
ELI LILLY AND COMPANY20.11%316 361
ROCHE HOLDING AG-14.13%271 357
ABBVIE INC.3.61%248 046
PFIZER, INC.-25.28%241 836